WebMainz Biomed NV is a molecular genetics cancer diagnostic company. The firm is engaged in the developing of market-ready molecular genetic diagnostic solutions for life-threatening conditions. WebApr 10, 2024 · Year End Cash Balance of $17.1 Million. BERKELEY, Calif. and MAINZ, Germany, April 10, 2024 (GLOBE NEWSWIRE) — Mainz Biomed N.V. MYNZ (“Mainz …
Mainz Biomed Launches Number of Educational Events in
WebApr 10, 2024 · Early identification of Cancer saves lives. To be effective, cancer detection needs to be simple, readily available, and affordable. We develop innovative products … OUR BUSINESS CONCEPT & PIPELINE SAVES LIVES AND HEALTH CARE … COLOALERT TARGET CONDITION COLORECTAL CANCER 37 … Mainz BioMed is developing proprietary genetic testing methods for pancreatic … NEWS English / EnglischGerman / Deutsch All Corporate News All All Corporate … CONTACT CONTACT US To contact us send us a message using the form or … CAREERS CAREERS At Mainz BioMed, every day is about making a difference … WebFeb 21, 2024 · BERKELEY, Calif. and MAINZ, Germany, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today the execution of its option from Uni Targeting Research AS to … top sports podcasts rankings spotify
Home - Mainz Biomed
WebOct 28, 2024 · About. Mainz Biomed B.V. ( NASDAQ: MYNZ) is a molecular genetics cancer diagnostic company incorporated in 2024. Mainz Biomed was formed to acquire … WebApr 10, 2024 · Year End Cash Balance of $17.1 Million. BERKELEY, Calif. and MAINZ, Germany, April 10, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular ... WebJan 3, 2024 · Mainz BioMed NV. BERKELEY, US and MAINZ, Germany , Jan. 03, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic ... top sports private equity firms